Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -236,876 | -6,185 | -2,047 | N/A | N/A |
| Depreciation Amortization | 1,510 | 473 | 323 | N/A | N/A |
| Income taxes - deferred | -302 | 0 | N/A | N/A | N/A |
| Accounts receivable | N/A | 80 | -173 | N/A | N/A |
| Accounts payable and accrued liabilities | 627 | -347 | 700 | N/A | N/A |
| Other Working Capital | 282 | -793 | 856 | N/A | N/A |
| Other Operating Activity | 209,454 | 1,354 | -327 | 0 | 0 |
| Operating Cash Flow | $-25,305 | $-5,418 | $-668 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -171,165 | 0 | N/A | N/A | N/A |
| PPE Investments | -2,241 | -235 | -3 | N/A | N/A |
| Net Acquisitions | -1,818 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-175,224 | $-235 | $-3 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 316,452 | 63,118 | 676 | N/A | N/A |
| Debt Repayment | -132 | -53 | -1 | N/A | N/A |
| Common Stock Issued | 8,226 | 1,342 | 230 | N/A | N/A |
| Common Stock Repurchased | -4,798 | 0 | N/A | N/A | N/A |
| Other Financing Activity | -2,415 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $317,333 | $64,407 | $905 | $N/A | $N/A |
| Beginning Cash Position | 59,104 | 350 | 116 | N/A | N/A |
| End Cash Position | 175,908 | 59,104 | 350 | N/A | N/A |
| Net Cash Flow | $116,804 | $58,754 | $234 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,305 | -5,418 | -668 | N/A | N/A |
| Capital Expenditure | -2,241 | -235 | -3 | N/A | N/A |
| Free Cash Flow | -27,546 | -5,653 | -671 | 0 | 0 |